collaborating with pharma · collaborating with pharma by darren spevick chair, emig digital health...

Collaborating with Pharma

By Darren Spevick Chair, EMIG Digital Health Managing Partner – Eventum PartnersJune 2019

Agenda

Introduction to

Darren Spevick and Eventum Partners

EMIG Digital Health Special Interest Group

Collaborating with the pharmaceutical industry

Eventum Partners

Darren Spevick – 20 years recruitment experience in pharma, life sciences, digital health

Set up Eventum Partners in 2013

Focus on senior level interim and permanent appointments

We work with providers of healthcare products (pharma / med tech), health technology and health services

EMIG Digital Health

EMIG – Ethical Medicines Industry Group

Represents c200 UK SME Pharma companies

Alexion, Allergan, Amgen, Astellas, Baxter, Celgene, Gilead, Sandoz, Takeda, Teva…

Digital Health SIG set up 2016

McLaren Applied Technologies, Oviva, Aparito, Draper & Dash, Benevolent AI, Medisafe, Cognitant

Imperial College Health Partners, MHRA, Deloitte, Digitalhealth.london, NHS Digital

Pharma already collaborates

Pharma

CRO

NHS

Academia

Software

Data

Charities

Patient

Groups

Service provides

Why collaborate?

Pharma

TechnologyServices

Patient

Why collaborate?

Pharma Tech

Pharma and Technology

Challenges of collaboration

SME pharma are interested - limited resource

Big pharma – have the resource, are they really committed?

Demonstrate the value proposition of the technology =

does it deliver cost savings?

patient benefits?

increased sales?

Who is going to pay for the technology?

Regulations?

Legal / commercial agreements?

Examples of collaboration

Recent collaborations Swedish startup Pilloxa announces collaboration with

Novartis division – Sandoz Nordics AstraZeneca and BenevolentAI have begun a long term

collaboration AI and machine learning for the discovery and development of new treatments

Owlstone Medical has announced a strategic collaboration with Actelion Pharmaceuticals to discover and validate a breath-based test to help facilitate the early diagnosis of pulmonary hypertension

Eli Lilly has collaborated with Atomwise for a multiyear discovery agreement to use its AI to generate new leads for up to 10 of its drug targets, at up to $1 million a pop

Summary

Collaborations are happening

Pharma industry is engaging

Collaborations are the key for digital health / therapeutics to transform the way healthcare is managed and delivered

Thank you

Let’s collaborate

T | 0044 203 670 1111M | 0044 7974 369111E | darrenspevick@eventumpartners.comW | eventumpartners.com

| https://www.linkedin.com/company/eventum-partners